Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Stem cell reports·2026
Same author

Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.

Redox biology·2026
Same author

Spatial analysis of HPV-associated cervical intraepithelial neoplastic tissues demonstrate distinct immune signatures associated with cervical cancer progression.

The Journal of pathology·2025
Same author

An alternate receptor for adeno-associated viruses.

Cell·2025
Same author

The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases.

The Journal of investigative dermatology·2025
Same author

Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025

Related Experiment Video

Updated: Feb 13, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.3K

No Vacillation on HPV Vaccination.

Douglas Sipp1, Ian H Frazer2, John E J Rasko3

  • 1RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe, Japan; Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan; Keio Global Research Institute, 2 Chome-15-45 Mita, Minato-ku, Tokyo, Japan; RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Building, 15th floor, 1-4-1 Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan.

Cell
|March 10, 2018
PubMed
Summary

Human papillomavirus (HPV) vaccines are safe and prevent cancer, but low global uptake hinders population immunity. Policy changes are needed to increase worldwide HPV vaccination coverage and save lives.

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.0K

Related Experiment Videos

Last Updated: Feb 13, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.3K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.0K

Area of Science:

  • Oncology
  • Vaccinology
  • Public Health

Background:

  • The safety and anti-cancer benefits of human papillomavirus (HPV) vaccines are well-established.
  • Despite overwhelming evidence, global HPV vaccine uptake remains insufficient to achieve herd immunity.

Purpose of the Study:

  • To review policy measures that can enhance global HPV vaccine coverage.
  • To identify strategies for increasing HPV vaccination rates worldwide to maximize cancer prevention.

Main Methods:

  • This study synthesizes existing evidence on HPV vaccine efficacy and safety.
  • It analyzes factors contributing to disparities in global vaccine uptake.
  • Policy recommendations are derived from a review of successful public health interventions.

Main Results:

  • Significant variations in HPV vaccine coverage exist across different countries.
  • Current uptake levels are below the threshold required for effective population-level cancer prevention.
  • Specific policy interventions can demonstrably improve vaccination rates.

Conclusions:

  • Implementing targeted policy measures is crucial for improving global HPV vaccine coverage.
  • Increased vaccination rates will lead to substantial reductions in HPV-related cancers.
  • Global collaboration is essential to ensure equitable access and uptake of HPV vaccines.